Clinical Care Options

User Name

Password

Remember Me

Register Forgot Password

Search Site


	CCO Hepatitis Home Featured Content Update on Resistance to HBV and HCV Therapy 2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.		CCO HIV Home Featured Content New Issue: HIV Journal Options Expert faculty members discuss the latest journal articles important for clinical practice.		CCO Oncology Home Featured Content GI Cancer Meeting Coverage From Orlando Review new GI cancer data from the Orlando meeting. Download summary slides.


	Now Available from Clinical Care Options Audio Expert Highlights Listen to Audio Expert Highlights From the 2008 EASL Meeting Expert Recap Update on the Management of Treatment Experienced Patients CCO Bookstore Free Monograph: Diagnosis and Treatment of Cutaneous T-Cell Lymphoma Clinical Management Series The Role of Integrase Inhibitors in HIV Management Downloadable Slides Early Breast Cancer: Endocrine Therapy Expert Analysis Hepatitis and Opportunistic Coinfections CCO Independent Conference Coverage 2008 EASL Meeting in Milan Interactive Case Challenge Clinical Management of a 69-Year-Old Man With Intermediate-1-Risk Myelodysplastic Syndrome Interactive Decision Support Tool New Data Update: Drug-Drug Interactions in HIV-Infected Patients				CCO Live Meetings Hepatitis 6th Annual Clinical Care Options Hepatitis Symposium HBV Election 2008 Meet the Clinical Candidates HIV New Insights Into the Use of PIs Across the Treatment Spectrum Integrating New Antiretroviral Agents Into Therapeutic Strategies for Treatment-Experienced Patients Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents Oncology 7th International Symposium on Translational Research in Oncology Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment Attacking the Signal at the Switch: Unraveling the Mysteries of mTOR Inhibition in Multiple Tumor Types Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment